F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 41 filers reported holding F-STAR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,879,776 | +23.3% | 297,433 | -0.1% | 0.00% | – |
Q3 2022 | $1,524,000 | -18.0% | 297,803 | +0.3% | 0.00% | – |
Q2 2022 | $1,858,000 | +77.0% | 296,853 | +0.3% | 0.00% | – |
Q1 2022 | $1,050,000 | -28.2% | 295,947 | +1.6% | 0.00% | – |
Q4 2021 | $1,462,000 | -31.0% | 291,171 | +0.6% | 0.00% | – |
Q3 2021 | $2,118,000 | -14.6% | 289,388 | +0.2% | 0.00% | – |
Q2 2021 | $2,481,000 | +414.7% | 288,750 | +548.5% | 0.00% | – |
Q1 2021 | $482,000 | +8.8% | 44,523 | -0.7% | 0.00% | – |
Q4 2020 | $443,000 | – | 44,820 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ridgeback Capital Investments L.P. | 1,834,360 | $9,208,000 | 5.02% |
DAFNA Capital Management LLC | 693,785 | $3,483,000 | 0.88% |
Atlas Venture Advisors, Inc. | 574,996 | $2,886,000 | 0.40% |
Atlas Venture Life Science Advisors, LLC | 599,524 | $3,010,000 | 0.28% |
Anson Funds Management LP | 309,703 | $1,555,000 | 0.15% |
Connolly Sarah T. | 53,001 | $266,000 | 0.15% |
Rock Springs Capital Management LP | 751,889 | $3,774,000 | 0.09% |
Point72 Asset Management, L.P. | 981,249 | $4,926,000 | 0.02% |
Eversept Partners, LP | 49,933 | $250,664 | 0.02% |
Private Capital Advisors, Inc. | 13,083 | $66,000 | 0.01% |